Neoplasms by Histologic Type  >>  epirubicin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00617370: Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Completed
N/A
38
US
epirubicin, cyclophosphamide, Paclitaxel,
Memorial Sloan Kettering Cancer Center, Amgen, Pfizer
Breast Cancer, Adenocarcinoma of the Breast
07/05
06/08
NCT00825669: Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection

Completed
N/A
100
RoW
TACE, TAE, Laser ablation, Microinvasive
Eastern Hepatobiliary Surgery Hospital
Hepatocellular Carcinoma
12/09
12/10

Download Options